New treatments for diabetes

N Engl J Med. 2007 May 24;356(21):2222; author reply 2222-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenosine Deaminase Inhibitors*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl Peptidase 4
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Drug Approval*
  • Drug Combinations
  • Glycoproteins / antagonists & inhibitors*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Metformin / therapeutic use*
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Triazoles / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Adenosine Deaminase Inhibitors
  • Dipeptidyl-Peptidase IV Inhibitors
  • Drug Combinations
  • Glycoproteins
  • Hypoglycemic Agents
  • Pyrazines
  • Triazoles
  • Metformin
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • Sitagliptin Phosphate